Limited expression of R5-tropic HIV-1 in CCR5-positive type 1-polarized T cells explained by their ability to produce RANTES, MIP-1α, and MIP-1β

Blood

Volumn 95, Issue 4, 2000, Pages 1167-1174

  Annunziato, Francesco ^b   Galli, Grazia ^b   Nappi, Filomena ^b   Cosmi, Lorenzo ^b   Manetti, Roberto ^b   Maggi, Enrico ^b   Ensoli, Barbara ^b   Romagnani, Sergio ^a  

^a Sezione di Immunoallergologia   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; GAG PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES;

ADULT; ARTICLE; CYTOKINE PRODUCTION; HELPER CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; IMMUNOREGULATION; MEMORY CELL; NEWBORN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRAIN DIFFERENCE; T LYMPHOCYTE ACTIVATION;

EID: 0034651774     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.4.1167.004k11_1167_1174     Document Type: Article

References (38)

1. Cheng-Mayer C, Seto D, Tateno M, Levy LA. Biological teatures of HIV-1 that correlate with virulence in the host. Science. 1988;240:80-82.
2. Tersmette M, de Goede REY, Al BJM, et al. Differential syncitium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncitium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol. 1988;62:2026-2032.
3. Asjo B, Morfeldt-Manson L, Albert J, et al. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet. 1986;2:660-662.
4. Schuitemaker H, Kootstra NA, de Goede RE, de Wolf F, Miedema F, Tersmette M. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncitium-inducing ability in primary T cell culture. J. Virol. 1991;65: 356-363.
5. Connor RI, Mohri H, Cao Y, Ho DD. Increased viral burden and cytopathicity correlate temporally with CD4 + T lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol. 1993;67:1772-1778.
6. Choe H, Farazan M, Sun Y, et al. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 1996;85: 1135-1148.
7. Berson JF, Long D, Doranz BJ, Rucker J, Jirik FR, Doms RW. A seven transmembrane domain receptor involved in fusion and entry of T-cell tropic human immunodeficiency virus type-1 strains. J Virol. 1996;70:6288-6295.
8. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science. 1996;272:872-877.
9. Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997;18:263-266.
10. Loetscher P, Uguccioni MG, Bordoli L, et al. CCR5 is characteristic of Th1 lymphocytes. Nature. 1998;391:344-345.
11. Bonacchi R, Biancni G, Bordignon Panina P, et al. Differential expression of chemokine receptors and chemotactic responsiveness of Th1 andTh2 cells. J Exp Med. 1998;187:129-134.
12. Jourdan P, Abbal C, Nora N, et al. IL-4 induces functional cell-surface expression of CXCR4 on human T cells. J Immunol. 1998;160:4153-4157.
13. Galli G, Annunziato F, Mavilia C, et al. Enhanced HIV expression during T helper 2-oriented responses due to the opposite regulatory effect of IL-4 and IFN-γ on Fusin/CXCR4. Eur J Immunol. 1998;28:3280-3290.
14. Suzuki Y, Koyanagi Y, Tanaka Y, et al. Determinant in human immunodeficency virus type 1 for efficient replication under cytokine induced CD4(+)T-helper 1 (Th1)- and Th2-type conditions. J Virol. 1999;73:316-24.
15. Penn ML, Grivel J-C, Schramm B, Goldsmith MA, Margolis L. CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue. Proc Natl Acad Sci USA. 1999;96:663-68.
16. Torres Y, Medrano FJ, Rey C, et al. Evidence for a role of T-helper type 2 cytokines in the acquisition of human immunodeficiency virus syncytium-inducing phenotype. Eur J Clin Invest. 1998;28: 930-936.
17. Romagnani S. Role for Th1/Th2 cytokine in HIV infection. Immunol Rev. 1994;140:73-92.
18. Bentwich Z, Kalinkovich A, Weisman Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today. 1995;16: 187-191.
19. Annunziato F, Manetti R, Cosmi L, et al. Opposite role for interleukin-4 and interferon-γ on CD30 and lymphocyte activation gene-3 (LAG-3) expression by activated naive T cells. Eur J Immunol. 1997;27:2239-2244.
20. Graham FL, Smiley J, Russell WC. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol. 1997;36: 59-74.
21. Helseth E, Kowalski M, Gabuzda D, Olshevsky U, Haseltine W, Sodroski J. Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants. J Virol. 1990;64:2416-2420.
22. Ensoli B, Buonaguro L, Barillari G, et al. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol. 1993;67: 277-287.
23. Connor RI, Sheridan KE, Ceradin D, Choe S, Landau R. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med. 1997;185:621-62B.
24. Clerici M, Shearer GM. A Th1 to Th2 switch is a critical step in the etiology of HIV infection. Immunol Today. 1993;14:107-111.
25. Maggi E, Mazzetti M, Ravina A, et al. Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science. 1994;265:244-248.
26. Graziosi C, Pantaleo G, Gant KR, et al. Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science. 1994;265:248-252.
27. Meyaard L, Otto SA, Hooibrink B, Miedema F. Quantitative analysis of CD4+ T cell function in the course of human immunodeficiency virus infection. Gradual decline of both naive and memory alloreactive T cells. J Clin Invest. 1994; 94:1947-1952.
28. Vyarnakam A, Matear PM, Martin SJ, Wagstaff M. Th1 cells specific for HIV-1 gag p24 are less efficient than Th0 cells in supporting HIV replication, and inhibit virus replication in Th0 cells. Immunology. 1995;86:85-90.
29. Tanaka Y, Koyanagi Y, Tanaka R, Kumazawa Y, Nishimura T, Yamamoto N. Productive and lytic infection of human CD4+ type 1 helper T cells with macrophage-tropic human immunodeficiency virus type 1. J Virol. 1997;71:465-470.
30. Meyaard L, Fouchier RA, Brouwer M, Hovenkamp E, Miedema F. Syncytium-inducing HIV-1 variants replicate equally well in all types of T-helper cell clones. AIDS. 1996;10:1598-1600.
31. Mikovits JA, Taub DD, Turkovski-Corrales SM, Ruscetti FW. Similar levels of human immunodeficiency virus type 1 replication in human Th 1 and Th2 clones. J Virol. 1998;72:5231-5238.
32. Schrum S, Probst P, Fleischer B, Zipfel PF. Synthesis of the CC-chemokine MIP-1 alpha, MIP-1 beta, and RANTES is associated with a type 1 immune response. J Immunol. 1996;157:3598-3604.
33. Trumpfheller C, Tenner-Racz K, Racz P, Fleischer B, Frosch S. Expression of macrophage inflammatory protein (MIP)-1 alpha, MIP-1beta, and RANTES genes in lymph nodes from HIV+ individuals: correlation with aTh1-type cytokine response. Clin Exp Immunol. 1998;112:92-99.
34. Del Prete G-F De Carli M, Almerigogna F, et al. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J. 1995;9:81-86
35. Maggi E, Annunziato F, Manetti R, et al. Activation of HIV expression by CD30 triggering in CD4+ T cells from HIV-infected individuals. Immunity. 1995;3:1-5.
36. Biswas P, Smith CA, Goletti O, Hardy EC, Jackson RW, Fauci AS. Crosslinking of CD30 induces HIV expression in chronically infected T cells. Immunity. 1995;2:587-596.
37. McDonald PP, Cassatella MA, Bald A, et al. CD30 ligation induces nuclear factor-κB activation in human T cell lines. Eur J Immunol. 1995;25:2870-2876.
38. Tsitsikow EN, Wright DA, Geha RS. CD30 induction of human immunodeficiency virus gene transcription is mediated byTRAF2. Proc Natl Acad Sci U S A 1997;94:1390-1395.